Abstract
CCAAT/enhancer binding proteins (C/EBPs) are key-regulators of cell differentiation and linked processes such as proliferation, apoptosis and gene expression in several organs. C/EBPs are also central for inflammatory responses and infectious defenses, but so far little is known of their role in lung diseases. However, a role for these intracellular proteins has recently been suggested in asthma, lung cancer and chronic bronchitis-COPD. In this mini-review, an overview of the biological roles of C/EBPs in lung is provided, together with a discussion of the recent studies suggesting a role for these transcription factors in the pathogenesis of some of our most common and severe lung diseases.
Keywords: Lung, CCAAT/enhancer binding proteins, transcription factors, lung cancer, asthma, chronic bronchitis, chronic obstructive pulmonary disease
Current Respiratory Medicine Reviews
Title: C/EBP Transcription Factors in Lung Disease
Volume: 1 Issue: 3
Author(s): Magnus Nord
Affiliation:
Keywords: Lung, CCAAT/enhancer binding proteins, transcription factors, lung cancer, asthma, chronic bronchitis, chronic obstructive pulmonary disease
Abstract: CCAAT/enhancer binding proteins (C/EBPs) are key-regulators of cell differentiation and linked processes such as proliferation, apoptosis and gene expression in several organs. C/EBPs are also central for inflammatory responses and infectious defenses, but so far little is known of their role in lung diseases. However, a role for these intracellular proteins has recently been suggested in asthma, lung cancer and chronic bronchitis-COPD. In this mini-review, an overview of the biological roles of C/EBPs in lung is provided, together with a discussion of the recent studies suggesting a role for these transcription factors in the pathogenesis of some of our most common and severe lung diseases.
Export Options
About this article
Cite this article as:
Nord Magnus, C/EBP Transcription Factors in Lung Disease, Current Respiratory Medicine Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157339805774597956
DOI https://dx.doi.org/10.2174/157339805774597956 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension
Current Drug Discovery Technologies New Frontiers in Cystic Fibrosis Therapy: The Case of Stem Cells
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Preface: MicroRNA: Short but not Small
MicroRNA Current Insights into Interethnic Variability in Testicular Cancers: Population Pharmacogenetics, Clinical Trials, Genetic Basis of Chemotherapy- Induced Toxicities and Molecular Signal Transduction
Current Topics in Medicinal Chemistry Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets Anticancer Agents: VTA or VDA
Current Bioactive Compounds Recent Highlights in the Synthesis of Anti-HCV Ribonucleosides
Current Medicinal Chemistry Targeted Therapies in Lung Cancer
Current Pharmaceutical Design Comparative Proteomics and Bioinformatics Analysis of Tissue from Non-Small Cell Lung Cancer Patients
Current Proteomics Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent
Anti-Cancer Agents in Medicinal Chemistry Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Carbonyl-Scavenging Drugs & Protection Against Carbonyl Stress-Associated Cell Injury
Mini-Reviews in Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Editorial from Editor-in-Chief
Current Respiratory Medicine Reviews Novel Immunotherapeutic Strategies for Invasive Fungal Disease
Current Drug Targets - Cardiovascular & Hematological Disorders Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Improved Therapeutic Efficacy of Topotecan Against A549 Lung Cancer Cells with Folate-targeted Topotecan Liposomes
Current Drug Metabolism Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design Mitosis-Targeting Natural Products for Cancer Prevention and Therapy
Current Drug Targets